Eric B. Haura
Molecular Biology · 2000–2014
A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 26 citations into it
- Oncology — 25 citations into it
Whom Eric B. Haura trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Timothy Yeatman (in Molecular Biology)
Papers from Eric B. Haura's perspective
Ordered by how strongly the researchers Eric B. Haura trusts endorse each paper. Same corpus, a different order for every researcher.
- STATs in oncogenesis (Oncogene)
- SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling (Molecular and Cellular Biology)
- The role of STATs in transcriptional control and their impact on cellular function (Oncogene)
- Angiogenesis as a therapeutic target (Nature)
- Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. (Blood)
- Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. (Proceedings of the National Academy of Sciences of the United States of America)
- STAT proteins: novel molecular targets for cancer drug discovery (Oncogene)
- A quantitative analysis of kinase inhibitor selectivity (Nature Biotechnology)
- Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. (Biochimica et Biophysica Acta)
- Interleukin-8 and human cancer biology. (Cytokine & growth factor reviews)
Their papers
- Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. (2000) — 1,381 citations
- Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis (2002) — 1,244 citations
- Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs (2014) — 1,641 citations
- Src kinases as therapeutic targets for cancer (2009) — 724 citations